Prostate Specific Antigen News and Research

RSS

New initiative aims to increase prostate cancer screening in African Americans men

African American men in Cuyahoga County have a 60% increased risk of being diagnosed with prostate cancer and an 80% increased risk of dying from prostate cancer compared to white men, according to data from the Case Comprehensive Cancer Center.

2 Mar 2021

New urine test could avoid unnecessary prostate cancer biopsies

A urine test based on University of Michigan Rogel Cancer Center research could have avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study that included more than 1,500 patients.

11 Feb 2021

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins Kimmel Cancer Center and 15 other medical centers.

11 Feb 2021

HKBU and CUHK jointly develop Spermine Risk Score for diagnosis of prostate cancer

Researchers from Hong Kong Baptist University and the Faculty of Medicine at The Chinese University of Hong Kong have jointly developed the Spermine Risk Score which, coupled with the use of a urine test, provides a non-invasive and more reliable method for the diagnosis of prostate cancer.

8 Feb 2021

New technique can rapidly diagnose prostate cancer from urine

Prostate cancer is one of the most common cancers among men. Patients are determined to have prostate cancer primarily based on PSA, a cancer factor in blood.

21 Jan 2021

New tests may help improve the selection of men considering prostate cancer surveillance

Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.

15 Jan 2021

Mediterranean diet has the potential to effect progression of prostate cancer

In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease.

7 Jan 2021

Genetic risk score can be used to determine risk of developing prostate cancer

Some racial and ethnic groups suffer relatively more often, and fare worse, from common ailments compared to others. Prostate cancer is one disease where such health disparities occur: risk for the disease is about 75 percent higher, and prostate cancer is more than twice as deadly, in Blacks compared to whites.

4 Jan 2021

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

1 Dec 2020

Negative biopsies during active surveillance for prostate cancer are associated with long-term outcomes

Can early-stage prostate cancer "vanish" during follow-up? More likely the cancer is just "hidden"--either way, negative biopsies during active surveillance for prostate cancer are associated with excellent long-term outcomes, reports a study in The Journal of Urology®.

18 Nov 2020

Active surveillance is a safe and viable option for men with low-risk prostate cancer

Men undergoing active surveillance for prostate cancer have very low rates - one percent or less - of cancer spread (metastases) or death from prostate cancer, according to a recent study published in The Journal of Urology®, an Official Journal of the American Urological Association.

9 Nov 2020

Study shows active surveillance to be safe for African American men with low-risk prostate cancer

Previous studies have shown that African American men are 2.4 times as likely to die from prostate cancer compared to non-Hispanic white men.

3 Nov 2020

New staging system can inform treatment decisions for non-metastatic prostate cancer

Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for men diagnosed with non-metastatic prostate cancer.

23 Oct 2020

Prostate Specific Antigen News and Research

New initiative aims to increase prostate cancer screening in African Americans men

New urine test could avoid unnecessary prostate cancer biopsies

Genomic test may help guide treatment decisions for patients with recurrent prostate cancer

HKBU and CUHK jointly develop Spermine Risk Score for diagnosis of prostate cancer

New technique can rapidly diagnose prostate cancer from urine

New tests may help improve the selection of men considering prostate cancer surveillance

Mediterranean diet has the potential to effect progression of prostate cancer

Genetic risk score can be used to determine risk of developing prostate cancer

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Negative biopsies during active surveillance for prostate cancer are associated with long-term outcomes

Active surveillance is a safe and viable option for men with low-risk prostate cancer

Study shows active surveillance to be safe for African American men with low-risk prostate cancer

New staging system can inform treatment decisions for non-metastatic prostate cancer

Researchers develop hand-held device to measure cancer biomarker

A promising tool for diagnosing prostate cancer

Medical experts emphasize new framework for future efforts to offer specific guidance on right-sizing care

PARP inhibitor can successfully treat a subset of advanced prostate cancer patients

Developing a blood test for prostate cancer

New blood test can detect prostate cancer and confirm the stage of the disease

PSMA PET/CT has high impact in the detection, management of recurrent prostate cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News